Ruggieri et al. Induction treatment strategy in multiple sclerosis: a review of past experiences and future perspectives. Multiple Sclerosis and Demyelinating Disorders (2018)
Cerqueira JJ, et al. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):844-850.
中华医学会神经病学分会神经免疫学组. 多发性硬化诊断与治疗中国指南（2023版）[J]. 中华神经科杂志,2024,57(01)：10-23.
Hauser SL, et al. Effect of ofatumumab on NEDA-3: analysis from the pooled Phase 3 ASCLEPIOS I and II trials. Poster presented at EAN 2020. LB62
Heinz Wiendl,et al. ePresentation at the annual meeting of the European Academy of Neurology, 2020
Ludwig Kappos,et al. Five-Year Efficacy Outcomes of Ofatumumab in Relapsing MS Patients: Insights From ALITHIOS Open-label Extension Study. EPR-097. Poster Presentation at European Academy of Neurology (EAN), 2023.
Hauser SL, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med. 2020 Aug 6;383(6):546-557.
Data on file. OMB157G (ofatumumab) OMB157G 5.3.5.3. Statistical overview. Novartis Pharmaceuticals Corp; East Hanover, NJ. December 2019.
Jeffrey A. Cohen, et al. Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis. AAN 2023. P8.004.
Kristen Krysko, et al. C174 presentation at American Academy of Neurology Annual Meeting, Denver, CO, USA; April 13-18, 2024
Dalia L Rotstein, et al. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. JAMA Neurol. 2015 Feb;72(2):152-8.
Hauser SL, et al. Presented at ECTRIMS 2019. OP336.
Valor L, et al. Treatment with monoclonal antibodies and pregnancy in women with systemic inflammatory diseases: A special situation. Reumatol Clin. 2016 Nov-Dec;12(6):359-360.
KESIMPTA. Prescribing information. East Hanover, NJ: Novartis Pharmaceuticals Corp. 2020.
Sandra Vukusic, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 2004 Jun;127(Pt 6):1353-60.
Maria Houtchens, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Sep 11;7(6):e890.
